posted on 2025-03-13, 14:34authored byChuntao Wang, Zi-Hao Liao, Rui Wu, Kai Chen, Shifa Zhu
The 1-dihydrobenzazepine skeleton has emerged as a privileged
structural
motif in bioactive molecules. However, due to a lack of asymmetric
methodology, access to chiral 1-dihydrobenzazepines has remained limited.
Herein, we report the first intermolecular asymmetric cycloisomerization
of benzo-fused enynes for the synthesis of chiral 1-dihydrobenzazepines
via dirhodium catalysis. This methodology features high efficiency
(up to 98% yield), high enantioselectivity (up to 99% ee), and broad
scope of nucleophiles, including oxygen nucleophiles (alcohols, phenols,
and carboxylic acids) and carbon nucleophiles (silyl enol ethers).
Theoretical and experimental mechanistic studies reveal that the reaction
pathway encompasses an asymmetric cycloisomerization, which gives
rise to a dirhodium carbene containing a donor–acceptor (D-A)
cyclopropane moiety, followed by a ring-opening process and stereoselective
nucleophilic attack by external nucleophiles on the cyclopropyl ring.
Control experiments demonstrate the pivotal role of the terminal group
capped on the alkynyl group of substrates in achieving good efficiency.